Viewing Opinion | StockChase

Teva Pharmaceutical (TEVA-N) opinion on 2017-01-11

Last Price Recorded: 21.4800 on 2018-01-17

ON STOCKCHASE SINCE Dec 2000

biotechnology/pharmaceutical
biotechnology/pharmaceutical
DON'T BUY

Christine Poole
Teva Pharmaceutical was $34.280 at time of opinion
Owned : No

A generic manufacturer, but do have some branded drugs. The company has been experiencing quite a bit of competition on one of their key branded drugs, so the profit growth is very uncertain, and the share price responded accordingly. There is just not enough clarity going forward.

UNKNOWN

All opinions for TEVA-N (241)

45 BUY
4 BUY on WEAKNESS
47 COMMENT
42 DON'T BUY
13 HOLD
2 PARTIAL BUY
26 PAST TOP PICK
8 SELL
3 STRONG BUY
44 TOP PICK
1 VAGUE
4 WAIT
2 WATCH
View All

More experts covering TEVA-N

SAVE
Add TEVA-N to Watch List

All opinions for TEVA-N (241)

45 BUY
4 BUY on WEAKNESS
47 COMMENT
42 DON'T BUY
13 HOLD
2 PARTIAL BUY
26 PAST TOP PICK
8 SELL
3 STRONG BUY
44 TOP PICK
1 VAGUE
4 WAIT
2 WATCH
View All

More experts covering TEVA-N

SAVE
Add TEVA-N to Watch List

Last 60 Days Opinions

COMMENT
6 days ago
COMMENT
1 week ago
DON'T BUY
1 week ago
DON'T BUY
1 month ago
COMMENT
1 month ago
COMMENT
1 month ago
DON'T BUY
1 month ago
PAST TOP PICK
1 month ago
DON'T BUY
1 month ago

No Comments.


You must be logged in to comment.

Successfully Saved Company